我要投票 燃石医学在基因检测行业中的票数:112
· 外 推 电 报 ·
2025-03-04 03:55:48 星期二

【燃石医学是哪个国家的品牌?】

燃石医学是什么牌子?「燃石医学」是 北京博宁洛克生物科技有限公司 旗下著名品牌。该品牌发源于广东省广州市,由创始人汉 * 生在2014年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力燃石医学品牌出海!通过在本页面挂载燃石医学品牌的产品链接和联系邮箱,可以提高燃石医学产品曝光!跨境电商爆单神器,目前只要100元/年哦~

燃石医学成立于2014年3月,在北京、上海、广州建设有超过10000平方米的检验所、研发中心和GMP车间。燃石医学专注于肿瘤患者个体化治疗指导,以二代测序及医学生物信息学为核心,常规肿瘤分子病理检测为基石,打造肿瘤个体化治疗临床检测服务及科研一站式解决方案。

燃石医学拥有一支专业的生物信息学分析和研发队伍、以及在运营管理方面的业内团队。燃石医学更是一家拥有临床医学部的第三方临床检验机构。公司成立之初,便获得了风险投资机构北极光创投及联想之星4300万人民币的联合投资。燃石医学将这笔资金投放在实验室建设和产品研发上,一份耕耘一份收获,燃石医学创始人汉雨生带领着燃石团队,在肿瘤个体化治疗临床转化的道路上披荆斩棘,推动了二代测序技术在肿瘤临床诊断领域的转化。

目前,燃石医学已针对不同癌种、不同临床阶段开发了30余种检测产品,涉及肿瘤早筛、肿瘤良恶性判断、肿瘤靶向用药伴随检测、肿瘤复发监控及肿瘤遗传检测。

同时,燃石医学积极寻求与国内医疗机构、国际设备商、药企的深度合作,以强大的研发能力、出色的产品设计及优异的产品性能,赢得了众多医学专家及行业领导公司的青睐,已经与Illumina、阿斯利康制药、Agilent、CTONG达成战略合作。

此外,燃石医学提供一站式NGS平台解决方案,推进NGS检测落地医院病理科,惠及更多肿瘤患者。目前,燃石是通过国家食品药品监督管理总局(CFDA)审核进入《创新医疗器械特别审批程序》的肿瘤应用方向NGS公司,更已于近期获得CFDA发出的首张基于Illumina测序平台肿瘤应用方向NGS检测产品的《医疗器械注册申请受理通知书》。 

精准医疗时代刚刚来临,预示着我们的长途跋涉才刚刚启程。燃石医学将会用科学守护生命之光!


英文翻译:Founded in March 2014, Firestone medicine has more than 10000 square meters of inspection institutes, R & D centers and GMP workshops in Beijing, Shanghai and Guangzhou. Firestone medicine focuses on the guidance of individualized treatment of tumor patients, with the core of second-generation sequencing and medical bioinformatics, and the cornerstone of conventional tumor molecular pathological detection, to create a one-stop solution for clinical detection service and scientific research of individualized treatment of tumor. Firestone medicine has a professional bioinformatics analysis and R & D team, as well as an industry team in operation management. Burn stone medicine is a third-party clinical laboratory with clinical medicine department. At the beginning of the company's establishment, it obtained a joint investment of 43 million yuan from the venture capital organization northern lights venture capital and Lenovo star. This fund is invested in laboratory construction and product research and development by Firestone medicine, and it's hard work and harvest. Under the leadership of Firestone team, Han Yusheng, founder of Firestone medicine, cut through thorns on the road of clinical transformation of tumor individualized treatment, promoting the transformation of second-generation sequencing technology in the field of tumor clinical diagnosis. At present, Firestone medicine has developed more than 30 detection products for different types of cancer and different clinical stages, involving early screening, benign and malignant judgment, concomitant detection of targeted drug use, tumor recurrence monitoring and tumor genetic detection. At the same time, Firestone medical actively seeks deep cooperation with domestic medical institutions, international equipment manufacturers and pharmaceutical companies, with strong R & D capabilities, excellent product design and excellent product performance, it has won the favor of many medical experts and industry leading companies, and has reached strategic cooperation with Illumina, AstraZeneca pharmaceutical, Agilent and ctong. In addition, Firestone medicine provides a one-stop ngs platform solution to promote the implementation of NGS detection in the pathology department of the hospital, benefiting more cancer patients. At present, burnstone is a tumor application direction NGS company that has entered the special approval procedure for innovative medical devices through the review of the State Food and Drug Administration (CFDA), and has recently obtained the first acceptance notice of medical device registration application issued by CFDA based on the products detected by ngs, tumor application direction of Illumina sequencing platform. The era of precision medicine is just coming, which indicates that our long journey has just begun. Burning stone medicine will protect the light of life with science!

本文链接: https://www.waitui.com/brand/adaca84fc.html 联系电话:请联系客服添加

千城特选小程序码

7×24h 快讯

跃岭股份:杰思金材将成为公司第一大股东,股票明起复牌

36氪获悉,跃岭股份公告,公司控股股东、实际控制人林仙明、林万青、林信福、林申茂、林平、林斌与北京杰思金材科技有限公司签署《股份转让协议》,林氏家族合计转让的股份数量为62,875,020股(占上市公司股份总数的24.5606%),转让完成后,杰思金材将成为公司第一大股东,公司实际控制人将变更为王冠然。公司股票自2025年3月4日起复牌。

2小时前

深圳:推动深圳数据交易所打造国家级数据交易所,发放“语料券”

36氪获悉,深圳市工业和信息化局印发《深圳市加快打造人工智能先锋城市行动计划(2025—2026年)》。加快构建行业语料集。充分利用深圳产业丰富优势,持续构建行业语料集,支撑垂类模型训练。打造高价值垂类数据集,重点培育医疗、教育、交通等高价值垂类数据集,汇聚建成3PB中文语料数据。培育建设重点行业可信数据空间,鼓励行业企业、互联网平台企业联合研究机构和行业组织,试点建设医疗等行业可信数据空间,释放行业数据价值。推动深圳数据交易所打造国家级数据交易所,发放“语料券”,促进人工智能语料共享和交易。

2小时前

美股大型科技股盘前多数上涨,特斯拉涨超3%

36氪获悉,美股大型科技股盘前多数上涨,截至发稿,特斯拉涨超3%,Arm涨超1%,奈飞涨0.91%,亚马逊涨0.88%,Meta涨0.77%,谷歌涨0.72%,微软涨0.49%;英伟达跌0.23%,苹果跌0.11%。

2小时前

热门中概股美股盘前多数下跌,理想汽车跌超8%

36氪获悉,热门中概股美股盘前多数下跌,截至发稿,理想汽车跌超8%,小鹏汽车跌超5%,蔚来、新东方跌超2%,京东跌超1%,网易跌0.63%,百度跌0.12%;阿里巴巴、拼多多涨超1%。

2小时前

四连板恒为科技:公司昇腾Deepseek一体机尚在样机研发推广阶段

36氪获悉,恒为科技公告,股票价格偏离公司基本面较大,存在估值较高风险。后续公司股票价格存在大幅上涨后下跌的风险。公司昇腾Deepseek一体机在AI服务器上安装部署Deepseek大模型并进行调优,目前市场上有多家公司宣布推出一体机,公司的产品竞争力尚未得到市场验证,目前尚在样机研发推广阶段,没有形成销售订单,也没有产生收入,公司与深度求索无业务往来。

2小时前

本页详细列出关于赛福基因的品牌信息,含品牌所属公司介绍,赛福基因所处行业的品牌地位及优势。
咨询